Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 USD | +0.48% |
|
-0.12% | -19.15% |
Jun. 17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
Jun. 17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
596M | - | |||||
122B | ||||||
116B | ||||||
27.03B | - | |||||
20.36B | - | |||||
16.43B |
- Stock Market
- Equities
- ZYME Stock
- Charts Zymeworks Inc.
- Sector Chart